WHC is still in active development. Read this to understand our approach.
depiction of FFEARJCKVFRZRR-UHFFFAOYSA-N.svg
tripsit

met

Check on tripsit

psychonaut

MET

Check on psychonaut

pubchem

Methionine

Check on pubchem

druglab

MET

Check on druglab

drugmap

D-Methionine

Check on drugmap

drugmap

D-Methionine

Check on drugmap

Data

InChI: InChI=1S/C5H11NO2S/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)

Synonyms: (S)-2-Amino-4-(methylthio)butanoate,g-Methylthio-a-aminobutyric acid,METHIONINE [WHO-DD],L-Homocysteine, S-methyl-,gamma-Methylthio-alpha-aminobutyric acid,MFCD00063097,Liquimeth,D00019,METHIONINE [USAN],L-2-Amino-4-methylthiobutyric acid,L-Methionine, Pharmaceutical Secondary Standard; Certified Reference Material,METHIONINE [HSDB],NCGC00160620-02,L-2-Amino-4-(methylthio)butanoic acid,Acimethin,L-2-Amino-4methylthiobutyric acid,L-alpha-Amino-gamma-methylmercaptobutyric acid,L-(-)-Methionine,63-68-3,(S)-methionine,Methilanin,gamma-methylthio-alpha-aminobutyrate,BP-31235,METHIONINE [EP MONOGRAPH],LEUCINE IMPURITY B [EP IMPURITY],S-Methionine,L-Methionine-[34S],D-Methionine-(methyl-13C),C-11 Met,s5633,L-Methionine, labeled with carbon-11,2-Amino-4-methylthiobutanoic acid (S)-,Neo-methidin,Z756440050,NSC760117,BDBM50142500,CHEBI:16643,D-2-Amino-4-(methylthio)butanoic acid,AE28F7PNPL,METHIONINE [USP MONOGRAPH],CCG-266196,1006386-95-3,L-METHIONINE [USP-RS],Z1250208671,L-Met,a-Amino-g-methylmercaptobutyric acid,METHIONINE [MI],L-Methionine-34S,L(-)-amino-alpha-amino-alpha-aminobutyric acid,GTPL4814,l-2-Amino-4-(methylthio)butyric acid,L-Lobamine, Cymethion,L-a-amino-g-methylthiobutyrate,Methionine [USAN:INN],METHIONINE [II],Butanoic acid, 2-amino-4-(methylthio)-, (S)-,C6CB5837-2B49-4B25-AAB0-D305DAFE26EB,CCRIS 5528,58576-49-1,2-Amino-4-methylthiobutanoate,Methionine (L-Methionine),L-METHIONINE [JAN],L-Methionine,(S),L-Methionin,(2S)-2-amino-4-(methylsulfanyl)butanoate,bmse000915,L-Methionine Z (TN),Methioninum [INN-Latin],L(-)-Methionin,(S)-2-amino-4-(methylthio)-Butanoate,(S)-(+)-Methionine,L(-)-Amino-gamma-methylthiobutyric acid,A5456,M0099,DB-029971,CS-W020566,Methionine (USP),63M683,Methionine (VAN),L-Methionine (H-Met-OH),L-Methionine, Cell Culture Reagent (H-L-Met-OH),METHIONINE [VANDF],AKOS000281626,(S)-2-Amino-4-(methylthio)butanoic acid,L-Methionine, United States Pharmacopeia (USP) Reference Standard,L-Methionine (JP17),L-Methionine, Vetec(TM) reagent grade, >=98%,M02945,C00073, D-Methionine-(methyl-13C), 99 atom % 13C,AKOS015852512,(2S)-2-Amino-4-methylsulfanylbutanoic acid,h-Met-oh,Poly-L-methionine,Toxin WAR,AM20100552,CCRIS 5536,Q22124685,NSC-22946,met,D70895,methylethyltryptamine,Methionine, L- (8CI),N-(2CT Resin)-L-Met-OH (200-400 mesh, > 0.3 mmol/g),Methionine, European Pharmacopoeia (EP) Reference Standard,METHIONINE [INN],IS_METHIONINE-METHYL-D3,ZINC1532529,SCHEMBL15702352,METHIONINE [INCI],EN300-52631,S-Methyl-L-homocysteine,G-methylthio-a-aminobutyrate,Methionine [USAN:USP:INN:BAN],h-Met-h,L-alpha-Amino-gamma-methylthiobutyric acid,(S)-2-amino-4-(methylthio)-Butanoic acid,UNII-AE28F7PNPL,NSC 22946,(S)-2-amino-4-(methylthio)butyric acid,HY-N0326,alpha-amino-alpha-aminobutyric acid,Toxin WAR (Bacillus thuringiensis strain PS205C),EINECS 200-562-9,M-3100,L-alpha-amino-gamma-methylthiobutyrate,AS-10898,L-Methioninum,(R)-2-Amino-4-(methylmercapto)butyric acid,racemic methionine,(2S)-2-amino-4-(methylsulfanyl)butanoic acid,alpha-amino-gamma-methylmercaptobutyrate,C-11 Methionine,2-Amino-4-(methylthio)butyric acid, (S)-,METHIONINE [MART.],NCGC00160620-01,Metionina [DCIT],DB00134,Pharmakon1600-01301006,H-Met-2-Chlorotrityl Resin,2-Amino-4-(methylthio)butyrate,METHIONINE, L-,Methioninum,MFCD00801344,L-METHIONINE [FCC],NSC-760117,F1905-8241,Soft tissue sarcoma-associated protein (human clone WO2004048938-SEQID-1139),SCHEMBL4226,methionine,(35S)Methionine,L-Methionine, Vetec(TM), 98.5%,A934626,L-Methionine, PharmaGrade, Ajinomoto, EP, JP, USP, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture,Polymethionine,A-amino-g-methylmercaptobutyrate,1pg2,(S)-2-Amino-4-(methylmercapto)butyric acid,DTXSID5040548,Cymethion,L-gamma-Methylthio-alpha-aminobutyric acid,L-a-Amino-g-methylthiobutyric acid,3h-l-methionine,L-Methionine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 99.0-101.0%,1qq9,M02939,carbon-11 methionine,CHEMBL42336,HSDB 4317,(L)-Methionine,L-Methionine, certified reference material, TraceCERT(R),L-methionine,metionina,L-Methionine, reagent grade, >=98% (HPLC),1wkm,L-Methionine, SAJ special grade, >=98.5%,L-Methionine, BioUltra, >=99.5% (NT),(2S)-2-amino-4-methylsulfanyl-butanoic acid,bmse000044


Estimated data

Solubility: 0.012 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 51.3% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.